Abstract:AIM: To establish a simplified method for generating peptide-major histocompatibility complex (MHC) class I tetramers.METHODS: cDNAs encoding the extracellular domain of human lymphocyte antigen (HLA)-A*0201 heavy chain (A2) and beta(2)-microglobulin (beta(2)m) from total RNA extracted from leukocytes of HLA-A2(+) donors were cloned into separate expression vectors by reverse transcription-polymerase chain reaction. The recombinant A2 and beta(2)m proteins were expressed in Escherichia coli strain BL21(DE3) and recovered from the inclusion body fraction. Soluble A2 proteins loaded with specific antigen peptides were refolded by dilution from the heavy chain in the presence of light chain beta(2)m and HLA-A2-restricted peptide antigens. The refolded A2 monomers were biotinylated with a commercial biotinylation enzyme (BirA) and purified by low pressure anion exchange chromatography on a Q-Sepharose (fast flow) column. The tetramers were then formed by mixing A2 monomers with streptavidin-PE in a molar ratio of 4:1. Flow cytometry was used to confirm the expected tetramer staining of CD8(+) T cells.RESULTS: Recombinant genes for HLA-A*0201 heavy chain (A2) fused to a BirA substrate peptide (A2-BSP) and mature beta(2)m from HLA-A2(+) donor leukocytes were successfully cloned and highly expressed in E. coli. Two soluble monomeric A2-peptide complexes were reconstituted from A2-BSP in the presence of beta(2)m and peptides loaded with either human cytomegalovirus pp65(495-503) peptide (NLVPMVATV, NLV; designated as A2-NLV) or influenza virus matrix protein Mp58-66 peptide (GILGFVFTL, GIL; designated as A2-GIL). Refolded A2-NLV or A2-GIL monomers were biotinylated and highly purified by single step anion exchange column chromatography. The tetramers were then formed by mixing the biotinylated A2-NLV or A2-GIL monomers with streptavidin-PE, leading to more than 80% multiplication as revealed by SDS-PAGE under non-reducing, unboiled conditions. Flow cytometry revealed that these tetramers could specifically bind to CD8(+) T cells from a HLA-A2(+) donor, but failed to bind to those from a HLA-A2(-) donor.CONCLUSION: The procedure is simple and efficient for generating peptide-MHC tetramers. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

Improved preparation of class I HLA tetramers and their use in detecting CMV-specific CTL.

[Preparation and Characterization of HLA-A * 0201 Monomer and Tetramer Loaded with HCMV Antigenic Peptide].

Preparation and Characterization of HLA-A*0201 Tetramer Loaded with IE-1316-324 Antigenic Peptide of Human Cytomegalovirus.

Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8(+) T Cells Within Donor Grafts: Its Associations with Cytomegalovirus Reactivation Following Unmanipulated Allogeneic Hematopoietic Stem Cell Transplantation.

Preparation and Characterization of HLA-A*0201 Tetramer Loaded with IE-1_(316-324) Antigenic Peptide of Human Cytomegalovirus

Quantification and Phenotypic Analysis of Hcmv Specific CTL in Peripheral Blood from HLA-A2+ Donors

Preparation of H-2Db Tetramer and Its Application in Enumerating the CD8+ T Cells Specific for Lymphocytic Choriomeningitis Virus

Monitoring of human cytomegalovirus infection in bone marrow and liver transplant recipients by antigenaemia assay and enzyme-linked immunosorbent assay.

Preparation and identification of HBc-HLA-A~* 1101-β_2m complex monomer and tetramer

Early Immune Surveillance to Predict Cytomegalovirus Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.

[Detection of HBV Specific Cytotoxic Lymphocytes Responses in Severe Hepatitis B Patients Using MHC-peptide Tetramer Flow Cytometry].

Development of Two Potential Diagnostic Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein B

Streptamer Versus Tetramer-Based Selection of Functional Cytomegalovirus-Specific T Cells.

Specific T-cell Receptor Gene Transfer Enhances Immune Response: A Potential Therapeutic Strategy for the Control of Human Cytomegalovirus Infection in Immunocompromised Patients

Rapid and sensitive identification of glycoprotein h genotypes in clinical human cytomegalovirus samples.

Improved Expression of HLA-A* 2402-BSP in Escherichia Coli and Its Tetramer Preparation

Development and characterization of HCMV recombinant subunit vaccines based on T-cell epitopes

Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant

Adoptive Therapy with Cytomegalovirus-Specific T Cells for Cytomegalovirus Infection after Haploidentical Stem Cell Transplantation and Factors Affecting Efficacy.

Preliminary Exploration of Hla-A*1101-Restricted Human Cytomegalovirus Glycoprotein B-Specific Cd8(+) T Cells in Allogeneic Stem-Cell Transplant Recipients

Procedure for Preparing Peptide-Major Histocompatibility Complex Tetramers for Direct Quantification of Antigen-Specific Cytotoxic T Lymphocytes